Emeis stock rebounds on support at €11.78 ahead of results
Emeis posts a sharp rebound during trading on Monday, after touching a low of €11.78 early in the day. The momentum remains under pressure: the stock has lost nearly 13% over one month, and first-half 2026 results are expected in three days.
An intraday rebound after breaking through the €11.94 support this morning
Emeis gains 2.18% to €12.20 during trading, but the day could have unfolded differently. The stock broke below its €11.94 support, plunging to €11.78, before recovering and clearly moving back above this threshold. This rebound from the trough brings the price back to the previous close (€11.94) in support position now validated on the upside. The configuration nevertheless remains fragile: the stock is trading 5.28% below its 20-day moving average at €12.88, 10.36% below its 50-day moving average at €13.61, and 12.86% below its 200-day moving average at €14.00.
These three moving averages form a technical ceiling weighing on any attempt at sustained rebound. The RSI at 27 signals a pronounced oversold configuration, consistent with the 13.29% drop recorded over the past month. This RSI level reflects selling exhaustion, but it does not guarantee a trend reversal as long as the moving averages remain so substantially above the price. In the SBF 120, which advances 0.95% during trading, Emeis ranks among the strongest gainers in the index, without erasing its monthly underperformance.
First-half results expected Wednesday, September 23, with S1 guidance already revised upward in July
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The key meeting looms on Wednesday, September 23, with the publication of first-half 2026 results. When publishing H1 2026 results on July 29, 2026, the group had revised its annual guidance upward, indicating that first-half performance had exceeded initial expectations and confirmed the momentum underway since 2025. This upward revision had then elicited a positive market reaction, as evidenced by the late August rebounds, before downward pressure resumed.
Over one year, the stock's performance remains slightly negative at -2.48%, illustrating persistent volatility around the issue despite documented operational improvement. In this context, the September 23 figures will constitute a concrete test to measure whether the momentum mentioned in July continued into the second quarter. The €14.47 resistance remains the technical target to monitor in case of a positive market reaction following publication.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 9M 2026
Key reported figures
Revenue: 4 543 millions d'euros
Quarterly revenue: 4 543 millions d'euros
Revenue growth: 3,5 %
Guidance from the release
« Les tendances observées lors des 9 premiers mois de l'année 2026 confortent emeis dans l'atteinte des objectifs pour 2026, objectifs par ailleurs relevés fin juillet. »
Risks mentioned
Health crises linked to flu outbreaks and heat waves requiring proactive management
Macroeconomic uncertainty and risk of return to inflation impacting operating expenses
Dependency on continued execution of operational efficiency programs such as the Boost initiative in France
Opportunities identified
Strong like-for-like revenue growth of +6.0% driven by improved occupancy rates and favorable pricing effects
Average occupancy rate now above 90% with +2.9 pts annual increase, particularly strong in nursing homes (+3.1 pts)
Structural demographic tailwind with European senior population aged 85+ expected to grow over 30% in next 10 years
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.